Powering Proteomics

EXPLORING THE HUMAN PROTEOME

Founded in 2000, SomaLogic – powered by an industry-leading technology platform and one of the largest clinical proteomic databases in the world – is a global leader in proteomics. The SomaScan Assay uses proprietary aptamer-based technology to offer a number of benefits, including the following.

• High throughput protein profiling through a scalable system of robotics. Today, we can assay over 1,000 clinical samples per day.
• Sensitivity. The tiered approach used for SomaScan Assay measurements enables the detection of very rare proteins consistently without sample pre-treatment.
• Largest high throughput menu on the market.
• Reproducibility. Because the SomaScan Assay has coefficients of variation under 5 percent, many fewer samples need to be run than using other technologies, saving time and money.
• Specificity. While most protein assays rely on polyclonal antibodies, which are highly variable, the SomaScan assay is powered by SOMAmers, which are individually selected for exquisite specificity to target proteins.
• Dynamic range. The SomaScan Assay is not subject to bias for high abundance proteins, and faithfully measures throughout a 10-log concentration range.